Institutional Ownership Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY). We have compiled data on the 719 institutions that hold shares in the stock, with a total of 111 Million shares, which have been reported (via 13F filing form) to have a value of $35.9 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
641,765
shares
|
$208 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.75%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
576,993
shares
|
$187 Million
0.06% of portfolio
|
Q4 2024
Reduced 3.54%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
554,606
shares
|
$180 Million
0.03% of portfolio
|
Q1 2025
Added 7.91%
|
|
Loomis Sayles & CO L P
|
May 14, 2025 Q1 2025 |
497,484
shares
|
$162 Million
0.19% of portfolio
|
Q1 2025
Reduced 1.11%
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
486,584
shares
|
$158 Million
0.13% of portfolio
|
Q1 2025
Reduced 3.46%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
480,967
shares
|
$156 Million
0.15% of portfolio
|
Q1 2025
Added 11.69%
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
458,314
shares
|
$149 Million
0.04% of portfolio
|
Q1 2025
Added 10.67%
|
|
Amundi
Paris, I0 |
May 15, 2025 Q1 2025 |
454,995
shares
|
$148 Million
0.04% of portfolio
|
Q1 2025
Reduced 8.32%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
448,881
shares
|
$146 Million
0.03% of portfolio
|
Q4 2024
Added 1.77%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
423,367
shares
|
$137 Million
0.02% of portfolio
|
Q1 2025
Reduced 7.03%
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
364,200
shares
|
$118 Million
0.07% of portfolio
|
Q1 2025
Added 0.44%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
346,100
shares
|
$112 Million
2.91% of portfolio
|
Q1 2025
Reduced 16.72%
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
May 15, 2025 Q1 2025 |
345,575
shares
|
$112 Million
1.33% of portfolio
|
Q1 2025
Reduced 5.44%
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2025 Q1 2025 |
337,231
shares
|
$109 Million
0.02% of portfolio
|
Q1 2025
Added 8.72%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
330,347
shares
|
$107 Million
0.11% of portfolio
|
Q1 2025
Reduced 31.92%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
309,819
shares
|
$101 Million
0.02% of portfolio
|
Q1 2025
Reduced 7.15%
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
309,589
shares
|
$101 Million
0.51% of portfolio
|
Q3 2024
Added 25.74%
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
309,219
shares
|
$100 Million
0.06% of portfolio
|
Q1 2025
Added 18.97%
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
307,288
shares
|
$99.8 Million
0.09% of portfolio
|
Q3 2022
Added 0.18%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
300,635
shares
|
$97.6 Million
0.2% of portfolio
|
Q1 2025
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
300,080
shares
|
$97.4 Million
0.02% of portfolio
|
Q1 2025
Added 8.35%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Apr 25, 2025 Q1 2025 |
291,476
shares
|
$94.6 Million
0.06% of portfolio
|
Q1 2025
Added 1.66%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
289,862
shares
|
$94.1 Million
0.08% of portfolio
|
Q1 2025
Reduced 20.17%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
287,337
shares
|
$93.3 Million
0.04% of portfolio
|
Q1 2025
Reduced 13.83%
|
|
Royal London Asset Management LTD
United Kingdom, X0 |
May 13, 2025 Q1 2025 |
286,943
shares
|
$93.2 Million
0.19% of portfolio
|
Q1 2025
Added 1.93%
|